MarketPeel
Insider Trading Intelligence
Pricing
…
RL

Redco II Master Fund, L.p.

FATE
DIRECTOR · FATE THERAPEUTICS INC · CIK 0001921783
FILING MIX · LIFETIME72%/28%
BUYS
41
SELLS
16
TOTAL VALUE
$218.64M
COMPANIES
2
ACTIVE SINCE
Jan 2024
HOLDINGS NOW
10,768,066
AVG SELL PX
$3.30
TRADE KIND
SHOWING 57 / 57
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
35 backtested trades · 8 horizons · 25 pending
Forward-return performance of every backtestable P/S trade by Redco II Master Fund, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d35+60.00%+5.15%+0.98%+4.17%-2.17%1.44
14d35+48.57%+17.25%+2.46%+14.79%+8.18%3.08
30d35+62.86%+41.81%+4.49%+37.32%+24.98%4.24
60d35+77.14%+37.23%+6.06%+40.84%+32.64%—
90d35+77.14%+33.83%+5.90%+27.93%+28.24%2.13
180d35(6 pending)+58.62%+28.52%+12.10%+16.42%+23.11%—
1y35(7 pending)+17.86%-20.32%+22.36%-42.67%-50.63%—
2y35(12 pending)+82.61%+36.58%+45.15%-8.57%-8.80%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FATE · 502,769 shares · as of Apr 20, 2026
03,221,0696,442,1399,663,20812,884,277SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 41 buys / 16 sellsCOVERAGE · 10 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
FATE
FATE THERAPEUTICS INC
PURCHASE
3,691,324——3,893,674Apr 20, 2026Apr 22, 2026 ↗View →
FATE
FATE THERAPEUTICS INC
PURCHASE
8,977,624——12,884,277Apr 20, 2026Apr 22, 2026 ↗View →
FATE
FATE THERAPEUTICS INC
SALE
162,013——0Apr 20, 2026Apr 22, 2026 ↗View →
FATE
FATE THERAPEUTICS INC
SALE
8,977,624——0Apr 20, 2026Apr 22, 2026 ↗View →
FATE
FATE THERAPEUTICS INC
PURCHASE
162,013——2,755,086Apr 20, 2026Apr 22, 2026 ↗View →
FATE
FATE THERAPEUTICS INC
SALE
3,691,324——0Apr 20, 2026Apr 22, 2026 ↗View →
FATE
FATE THERAPEUTICS INC
SALE
266,280——0Apr 20, 2026Apr 22, 2026 ↗View →
FATE
FATE THERAPEUTICS INC
SALE
266,280——0Apr 20, 2026Apr 23, 2026 ↗View →
FATE
FATE THERAPEUTICS INC
PURCHASE
266,280——502,769Apr 20, 2026Apr 22, 2026 ↗View →
FATE
FATE THERAPEUTICS INC
PURCHASE
266,280——502,769Apr 20, 2026Apr 23, 2026 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
2,634,506$3.28$8.64M12,666,731Apr 2, 2026Apr 2, 2026 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
2,529,491$3.28$8.29M10,265,297Apr 2, 2026Apr 2, 2026 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
162,517$3.80$617.4K12,794,788Apr 1, 2026Apr 2, 2026 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
169,265$3.80$643.0K15,301,237Apr 1, 2026Apr 2, 2026 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
196,229$3.75$736.3K15,470,502Mar 31, 2026Apr 2, 2026 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
188,407$3.75$706.9K12,957,305Mar 31, 2026Apr 2, 2026 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
3,846,153$3.90$15.00M3,846,153Oct 27, 2025Oct 28, 2025 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
3,846,153$3.90$15.00M3,846,153Oct 27, 2025Oct 28, 2025 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
15,734,267$3.43$54.00M15,734,267Jun 11, 2025Jun 13, 2025 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
12,465,234$3.43$42.78M12,465,234Jun 11, 2025Jun 13, 2025 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,000$3.81$190.5K13,145,712Dec 11, 2024Dec 13, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,000$2.28$114.0K13,095,712Dec 11, 2024Dec 13, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,000$3.81$190.5K15,666,731Dec 11, 2024Dec 13, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,000$2.28$114.0K15,616,731Dec 11, 2024Dec 13, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
26,656$2.07$55.2K8,163,265Dec 4, 2024Dec 6, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
50,672$2.07$104.9K15,516,059Dec 4, 2024Dec 6, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
25,352$2.07$52.5K15,566,731Dec 4, 2024Dec 6, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,672$2.07$104.9K15,566,731Dec 4, 2024Dec 6, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,672$2.07$104.9K13,045,712Dec 4, 2024Dec 6, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
26,656$2.07$55.2K8,136,609Dec 4, 2024Dec 6, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
26,656$2.07$55.2K6,133,837Dec 4, 2024Dec 6, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
400,000$2.81$1.12M15,669,217Jul 1, 2024Jul 3, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
400,000$2.81$1.12M12,995,040Jul 1, 2024Jul 3, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
8,163,265$4.81$39.28M8,163,265May 8, 2024May 10, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
6,107,181$4.81$29.39M6,107,181May 8, 2024May 10, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
107,590——107,590Feb 7, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
11,159——11,159Feb 2, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
144,517——144,517Feb 2, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
15,867——15,867Feb 1, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
19,700$3.38$66.7K1,180,136Feb 1, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
205,483——205,483Feb 1, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
150,000——150,000Jan 31, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000——100,000Jan 30, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
150,000——150,000Jan 29, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000——100,000Jan 26, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000——100,000Jan 25, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,000——50,000Jan 24, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
53,900——53,900Jan 16, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
93,424——93,424Jan 12, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000——100,000Jan 11, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000——100,000Jan 10, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000——100,000Jan 9, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000——100,000Jan 8, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,000——50,000Jan 5, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
28,652——28,652Jan 4, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
56,900——56,900Jan 3, 2024Feb 9, 2024 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
59,986$1.68$100.5K1,199,836Jan 3, 2024Feb 9, 2024 ↗View →
Other insiders · FATE
Loading peer insiders…
About this filer
CIK 0001921783
ROLE
Director
PRIMARY
FATE
COMPANIES
2
ACTIVE SINCE
Jan 2024
MARKETPEEL · /INSIDER/0001921783DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback